Hemato.AI
PrivateLast Round
Seed
Feb 27, 2025
Total Funding Raised
$7.6M
Company Overview
Hemato.AI is a health tech company that provides a cloud-based software service using artificial intelligence to analyze peripheral blood film images for the detection of hematological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemato.AI Comparables
Compare Hemato.AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| hema.to | 78% | |
| Mantiscope | 77% | |
| Techcyte, Inc. | 76% |
Hemato.AI Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Hemato.AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LUMO Labs | Seed |
| Elaia Partners | Seed |
| Becker Ventures | Seed |
| Bayern Kapital | Seed |
| High-Tech Gründerfonds | Seed |
| Cross Atlantic Angels | Seed |
| Heal Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2025
$4M round led by LUMO Labs.
Hemato.AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hemato.AI's valuation, stock price, and market status.
Is Hemato.AI a public or private company?
Hemato.AI is a private company.
What is the current stock price of Hemato.AI?
Hemato.AI is a private company, so its shares have no public market price. Caplight tracks Hemato.AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hemato.AI worth (valuation)?
Valuation information for Hemato.AI is not publicly available.
Can I buy Hemato.AI stock?
Hemato.AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hemato.AI's last funding round?
Hemato.AI's most recent funding round was Seed on February 27, 2025.
Who are the main investors in Hemato.AI?
Key investors in Hemato.AI include LUMO Labs, Elaia Partners.
Will Hemato.AI IPO soon?
No public IPO plans have been announced for Hemato.AI.
How can I track Hemato.AI secondary market activity?
Caplight tracks bids, offers, and trades in Hemato.AI's shares on secondary markets.